Quality improvement in acute stroke - The New York State Stroke Center Designation Project

被引:113
作者
Gropen, T. I.
Gagliano, P. J.
Blake, C. A.
Sacco, R. L.
Kwiatkowski, T.
Richmond, N. J.
Leifer, D.
Libman, R.
Azhar, S.
Daley, M. B.
机构
[1] Long Isl Coll Hosp, Dept Neurol, Brooklyn, NY 11201 USA
[2] SUNY Hlth Sci Ctr, IPRO, Brooklyn, NY 11203 USA
[3] New York State Dept Hlth, Healthcare Qual Initiat, New York, NY USA
[4] Columbia Univ, Med Ctr, Dept Neurol, New York, NY USA
[5] Columbia Univ, Med Ctr, Dept Epidemiol, New York, NY USA
[6] Long Isl Jewish Med Ctr, Dept Emergency Med, New Hyde Pk, NY 11042 USA
[7] Long Isl Jewish Med Ctr, Div Cerebrovasc Dis, New Hyde Pk, NY 11042 USA
[8] Long Isl Jewish Med Ctr, New Hyde Pk, NY 11042 USA
[9] N Shore Univ Hosp, Dept Neurol, Manhasset, NY USA
[10] Cornell Univ, New York Presbyterian Hosp, Weill Med Coll, Dept Neurol, New York, NY 10021 USA
[11] Lutheran Med Ctr, Stroke Ctr, Brooklyn, NY USA
[12] New York City Fire Dept, Louisville, KY USA
[13] Louisville Metro EMS, Louisville, KY USA
关键词
ACUTE ISCHEMIC-STROKE; TISSUE-PLASMINOGEN ACTIVATOR; EMERGENCY; ESTABLISHMENT; CARE;
D O I
10.1212/01.wnl.0000223622.13641.6d
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Many hospitals lack the infrastructure required to treat patients with acute stroke. The Brain Attack Coalition (BAC) published guidelines for the establishment of primary stroke centers. Objective: To determine if stroke center designation and selective triage of acute stroke patients improve quality of care. Methods: Baseline chart abstraction was performed on all stroke patients admitted to 32 hospitals serving Brooklyn and Queens, NY, from March to May 2002. Hospitals were invited to meet BAC guideline-based criteria. Adherence was verified by on-site visits. After designation, acute stroke patients were selectively triaged. Remeasurement data were collected from August to October 2003. Results: The authors abstracted 1,598 charts at baseline and 1,442 charts at remeasurement. From baseline to remeasurement, median times decreased for door to physician contact (25 vs 15 minutes, p = 0.001), CT performance for potential tissue plasminogen activator (t-PA) candidates (68 vs 32 minutes, p < 0.001), and t-PA administration ( 109 vs 98 minutes (p = NS). IV t-PA utilization increased from 2.4 to 5.2% (p < 0.005), select t-PA protocol violations decreased from 11.1 to 7.9% ( p = NS), and the stroke unit admission rate increased from 16 to 39% (p < 0.001). In stroke centers (n = 14) vs nondesignated hospitals (n = 18), there were shorter median times from door to physician contact (10 vs 25 minutes, p < 0.001), CT performance for potential t-PA candidates (31 vs 40 minutes, p = NS), and t-PA administration (95 vs 115 minutes, p < 0.05). Stroke centers, compared with nondesignated centers, admitted acute stroke patients to stroke units more often (55.9 vs 10.9%, p < 0.001). Conclusions: Stroke center designation and selective triage of acute stroke patients improved the quality of care, including access to timely thrombolytic therapy and stroke units.
引用
收藏
页码:88 / 93
页数:6
相关论文
共 21 条
[1]   Guidelines for the early management of patients with ischemic stroke - A scientific statement from the Stroke Council of the American Stroke Association [J].
Adams, HP ;
Adams, RJ ;
Brott, T ;
del Zoppo, GJ ;
Furlan, A ;
Goldstein, LB ;
Grubb, RL ;
Higashida, R ;
Kidwell, C ;
Kwiatkowski, TG ;
Marler, JR ;
Hademenos, GJ .
STROKE, 2003, 34 (04) :1056-1083
[2]   Intravenous tissue-type plasminogen activator for treatment of acute stroke - The standard treatment with alteplase to reverse stroke (STARS) study [J].
Albers, GW ;
Bates, VE ;
Clark, WM ;
Bell, R ;
Verro, P ;
Hamilton, SA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (09) :1145-1150
[3]   Recommendations for the establishment of primary stroke centers [J].
Alberts, MJ ;
Hademenos, G ;
Latchaw, RE ;
Jagoda, A ;
Marler, JR ;
Mayberg, MR ;
Starke, RD ;
Todd, HW ;
Viste, KM ;
Girgus, M ;
Shephard, T ;
Emr, M ;
Shwayder, P ;
Walker, MD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (23) :3102-3109
[4]  
Asplund K, 1997, BMJ-BRIT MED J, V314, P1151
[5]   Intravenous tissue plasminogen activator for acute ischemic stroke: Feasibility, safety, and efficacy in the first year of clinical practice [J].
Chiu, D ;
Krieger, D ;
Villar-Cordova, C ;
Kasner, SE ;
Morgenstern, B ;
Bratina, PL ;
Yatsu, FM ;
Grotta, JC .
STROKE, 1998, 29 (01) :303-303
[6]   Do the Brain Attack Coalition's criteria for stroke centers improve care for ischemic stroke? [J].
Douglas, VC ;
Tong, DC ;
Gillum, LA ;
Zhao, S ;
Brass, LM ;
Dostal, J ;
Johnston, SC .
NEUROLOGY, 2005, 64 (03) :422-427
[7]   Delay between stroke onset and emergency department evaluation [J].
Goldstein, LB ;
Edwards, MG ;
Wood, DP .
NEUROEPIDEMIOLOGY, 2001, 20 (03) :196-200
[8]   North Carolina stroke prevention and treatment facilities survey - Statewide availability of programs and services [J].
Goldstein, LB ;
Hey, L ;
Laney, R .
STROKE, 2000, 31 (01) :66-70
[9]   Early intravenous thrombolysis for acute ischemic stroke in a community-based approach [J].
Grond, M ;
Stenzel, C ;
Schmülling, S ;
Rudolf, J ;
Neveling, M ;
Lechleuthner, A ;
Schneweis, S ;
Heiss, WD .
STROKE, 1998, 29 (08) :1544-1549
[10]   Quality improvement and tissue-type plasminogen activator for acute ischemic stroke - A Cleveland update [J].
Katzan, IL ;
Hammer, MD ;
Furlan, AJ ;
Hixson, ED ;
Nadzam, DM .
STROKE, 2003, 34 (03) :799-800